Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

aXichem

2.45 SEK

+7.46 %

Less than 1K followers

AXIC A

First North Stockholm

Chemicals

Basic Materials

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+7.46 %
-10.58 %
-37.50 %
-1.61 %
+80.81 %
+67.24 %
-82.00 %
-94.64 %
-85.49 %

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company works mainly with Phenylcapsaicin, a natural analogue synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, and among individual pharmaceutical work areas. Operations are conducted on a global level, with headquarters in Malmö.

Read more
Market cap
144.83M SEK
Turnover
132.42K SEK
Revenue
8.57M
EBIT %
-184.71 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26/2
2026

Annual report '25

21/5
2026

Interim report Q1'26

17/6
2026

General meeting '26

All
Press releases
3rd party
ShowingAll content types
Third party research12/1/2025, 11:20 AM

aXichem: Behöver hetta till i Brasilien - VH Corp

* aXivite-order från Spanien * Ansökan om fast-track registrering i Brasilien * Vi behåller det motiverade värdet om 4,26 SEK per aktie För Q3 2025 rapporterade aXichem en försäljning om 4,6 MSEK vilket betydligt något lägre än våra högt ställda förv...

aXichem
Press release12/1/2025, 11:00 AM

Västra Hamnen Market Focus: aXichem: Behöver hetta till i Brasilien

aXichem
Regulatory press release11/28/2025, 7:30 AM

aXichem AB (publ), delårsrapport januari - september 2025

aXichem

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release11/24/2025, 10:00 AM

aXichem AB: aXichem's CEO Torsten Helsing Presents the Report for the Third Quarter 2025 in a Live Web Conference

aXichem
Press release11/24/2025, 10:00 AM

aXichem AB: aXichems VD Torsten Helsing presenterar rapport för tredje kvartalet 2025 i en direktsänd webbkonferens

aXichem
Press release11/10/2025, 7:30 AM

aXichem AB: aXichem, in collaboration with Chr. Olesen, applies for fast-track product registration in Brazil for phenylcapsaicin as a feed additive for dairy cattle

aXichem
Press release11/10/2025, 7:30 AM

aXichem AB: aXichem ansöker, i samarbete med Chr. Olesen, om fast-track registrering i Brasilien av phenylcapsaicin som fodertillsats för mjölkkor

aXichem
Press release9/24/2025, 2:33 PM

Analyst Group: Analyst Group intervjuar aXichems VD Torsten Helsing

aXichem
Press release9/22/2025, 7:00 AM

aXichem AB: aXichem participates at Vitality Month Conference, presenting aXivite and its translation of scientific innovation into consumer products for sports performance

aXichem
Press release9/22/2025, 7:00 AM

aXichem AB: aXichem deltar på Vitality Month Conference och presenterar aXivite och överföringen av vetenskaplig innovation till konsumentprodukter för sport och träning

aXichem
Press release9/17/2025, 6:30 AM

aXichem AB: aXichem confirms shipment of first call-off order for aXiphen to Chr. Olesen in Brazil, following successful scale-up of production

aXichem
Press release9/17/2025, 6:30 AM

aXichem AB: aXichem bekräftar leverans av den första avropsordern för aXiphen till Chr. Olesen i Brasilien, efter framgångsrik uppskalning av produktionen

aXichem
Press release9/10/2025, 8:00 AM

aXichem AB: Koncernintern överlåtelse hos LMK-bolagen

aXichem
Press release9/10/2025, 8:00 AM

aXichem AB: Intra-group transfer by LMK companies

aXichem
Third party research9/5/2025, 6:46 AM

Axichem: Försäljningstillväxt i prognosen - VH Corp

* Högre intäkter än väntat i Q2 * Första kommersiella ordern för aXiphen i Brasilien * Vi höjer det motiverade värdet till 4,26 (2,95) SEK per aktie Investerarnas intresse för aXichem-aktien fortsätter och aktien har stigit med 190 procent sedan årsskiftet...

aXichem
Press release9/5/2025, 6:30 AM

Västra Hamnen Market Focus: aXichem: Försäljningstillväxt i prognosen

aXichem
Regulatory press release8/28/2025, 6:30 AM

aXichem AB (publ), Interim Report January - June 2025

aXichem
Regulatory press release8/28/2025, 6:30 AM

aXichem AB (publ), delårsrapport januari - juni 2025

aXichem
Press release8/25/2025, 9:00 AM

aXichem AB: aXichems VD Torsten Helsing presenterar rapport för andra kvartalet 2025 i en direktsänd webbkonferens

aXichem
Press release8/25/2025, 9:00 AM

aXichem AB: aXichem's CEO Torsten Helsing Presents the Report for the Second Quarter 2025 in a Live Web Conference

aXichem
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.